DC Capital Partners
4
22M
4
0.24
1
2
- Stages of investment
- Areas of investment
Summary
DC Capital Partners appeared to be the VC, which was created in 2007. The main office of represented VC is situated in the Alexandria. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 6-7 partakers. The meaningful sponsors for the fund in investment in the same round are inVentiv Health, Versant Ventures, UPMC. In the next rounds fund is usually obtained by Advent Venture Partners.
The current fund was established by Thomas J. Campbell.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2003. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2009.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Medical Device. Among the most popular portfolio startups of the fund, we may highlight NeoGuide Systems. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.24
- Investments by industry
- Health Care (2)
- Robotics (1)
- Medical Device (1)
- Information Services (1)
- Web Hosting (1) Show 6 more
- Investments by region
- United States (4)
- Peak activity year
- 2003
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 0.75
- Avg. company exit year
- 9
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Werewolf Therapeutics | 20 Nov 2019 | Biotechnology, Life Science, Therapeutics | Early Stage Venture | 56M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.